- Complete breast tumor regressions induced by a single dose of ErSO-TFPy in mouse models, see In The Pipeline highlight
- Congratulations to postdoc Dr. Diana Ranoa on beginning her new position as an Assistant Professor in the Department of Biochemistry at UIUC!
- Listen to Let’s Talk Micro podcast on fabimycin and another on lolimicin.Listen to Let’s Talk Micro podcast on fabimycin and another on Lolamicin.
- Former Postdoc Prof. Sarah Tasker Featured in C&E NewsFormer Postdoc Prof. Sarah Tasker Featured in C&E News Sarah Tasker, an assistant professor of chemistry at Franklin & Marshall College, received an ACS PRF grant in 2018 with the proposal “Synthesis of Oxetanes via a Formal Formylation.”
- Rebecca Ulrich awarded the 15th Irving S. Sigal Postdoctoral FellowshipThe American Chemical Society has awarded Rebecca Ulrich of the University of Illinois Urbana-Champaign the 15th Irving S. Sigal Postdoctoral Fellowship for 2024–2026. Ulrich will conduct her fellowship studies with Deborah Hung of the Broad Institute starting Sept. 1. Read more…
- New antibiotic kills pathogenic bacteria, spares healthy gut microbes, see Nature paperResearchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut. Read More
- NEW: Rules for compound accumulation in P. aeruginosa published in Nature. UIUC Press Release Team discovers rules for breaking into Pseudomonas Researchers report in the journal Nature that they have found a way to get antibacterial drugs through the nearly impenetrable outer membrane of Pseudomonas aeruginosa, a bacterium that – once it infects a person… Read more: NEW: Rules for compound accumulation in <em>P. aeruginosa</em> published in <em>Nature</em>.
- NEW: A compound from the Hergenrother/Shapiro collaboration has been licensed and is advancing toward treatment of breast cancer.
Unprecedented Compound Takes a Step Toward Breast Cancer Clinical Trials Estrogen receptor-positive breast cancer is the most common form of breast cancer, affecting approximately 75% of breast cancer patients. In advanced and metastatic form, it is lethal, claiming the lives of nearly 350,000… Read more: NEW: A compound from the Hergenrother/Shapiro collaboration has been licensed and is advancing toward treatment of breast cancer. - Watch the Big Ten Network documentary on the UIUC COVID saliva test, featuring Dr. Diana Ranoa!Summary from YouTube: In 2020, the U.S. was in the grips of the COVID-19 pandemic without any vaccines in sight. Millions of college students were left wondering when they’d be able to resume in-person instruction. Researchers from various disciplines across the University of… Read more: Watch the Big Ten Network documentary on the UIUC COVID saliva test, featuring Dr. Diana Ranoa!
- Postdoctoral Positions Open in the Hergenrother LabThere are multiple postdoctoral positions open in the Hergenrother lab, for talented scientists with expertise/interest in either chemistry or biology. Interested individuals with expertise in any of the following areas should apply: • Biochemistry• Cell biology• Cancer biology• Microbiology• Medicinal chemistry• Synthetic chemistry… Read more: Postdoctoral Positions Open in the Hergenrother Lab